Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ)
CNY 19.51
(1.19%)
CNY 19.51
(1.19%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 30.65 Million CNY | -11.21% |
| 2022 | 34.52 Million CNY | -13.36% |
| 2021 | 39.85 Million CNY | 969.45% |
| 2020 | 3.72 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 30.33 Million CNY | 0.0% |
| 2024 Q1 | 31.35 Million CNY | 0.0% |
| 2024 Q3 | -1.72 Million CNY | 100.0% |
| 2023 Q2 | 32.72 Million CNY | -2.88% |
| 2023 Q4 | 30.65 Million CNY | -3.98% |
| 2023 Q3 | 31.92 Million CNY | -2.43% |
| 2023 FY | 30.65 Million CNY | -11.21% |
| 2023 Q1 | 33.69 Million CNY | -2.42% |
| 2022 Q2 | 40.63 Million CNY | 0.33% |
| 2022 FY | 34.52 Million CNY | -13.36% |
| 2022 Q4 | 34.52 Million CNY | -16.11% |
| 2022 Q3 | 41.16 Million CNY | 1.29% |
| 2022 Q1 | 40.5 Million CNY | 1.62% |
| 2021 FY | 39.85 Million CNY | 969.45% |
| 2021 Q4 | 39.85 Million CNY | -0.32% |
| 2021 Q3 | 39.98 Million CNY | 787.22% |
| 2021 Q2 | 4.5 Million CNY | 20.56% |
| 2021 Q1 | 3.73 Million CNY | 0.31% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q4 | 3.72 Million CNY | 0.0% |
| 2020 FY | 3.72 Million CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 100.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q2 | - CNY | -100.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |